Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Calytrix Bio

Tag: Calytrix Bio

Lilly Calytrix acquisition infographic with deal value and mutant CALR antibody details
  • Industry Insights

Lilly Calytrix Acquisition: $1.5B Bet on a Blood Cancer Mutation

Megan Wood5 hours ago010 mins

Eli Lilly will pay up to $1.5 billion for Calytrix Bio and its preclinical mutant-CALR antibody for essential thrombocythemia and myelofibrosis.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (353)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (105)
  • Uncategorized (1)

Recent Posts

  • Lilly Stipple Bio Deal: Why Eli Lilly Is Betting Up to $5.9B on Tumor-Only Targets
  • Lilly Calytrix Acquisition: $1.5B Bet on a Blood Cancer Mutation
  • J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo
  • CagriSema Weight Loss: Early Responders Lose 25% in New REDEFINE 1 Analysis
  • Lilly ObesityWeek 2026 Data: EloraTZP Hits 23% Weight Loss, Retatrutide Tackles Sleep Apnea
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.